Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Abrams Capital Management GTIV trades

David Abrams

David Abrams CENTERWELL HEALTH SERVICES I stake

total: 84

Trades details

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2014 Q2
Held for:
1 quarter
Latest activity:
2014 Q3
According to 2026 Q2 report, David Abrams doesn't hold any CENTERWELL HEALTH SERVICES I (GTIV) shares. To date, the estimated cost basis is nearly $15.06 for "buy" trades and estimated average "sell" price is $15.06. Abrams Capital Management first purchased GTIV in 2014 Q2, initially acquiring 975,170 shares. Since the initial investment in CENTERWELL HEALTH SERVICES I (GTIV), Abrams Capital Management has made 1 more transaction.

When did David Abrams sell CENTERWELL HEALTH SERVICES I (GTIV)?

David Abrams sold off the entire CENTERWELL HEALTH SERVICES I (GTIV) position in 2014 Q3.

When did David Abrams buy CENTERWELL HEALTH SERVICES I (GTIV)?

David Abrams first invested in CENTERWELL HEALTH SERVICES I (GTIV) in 2014 Q2 at the reported quarter-end price of $15.06 per share.

What's the cost basis of Abrams Capital Management's GTIV stake?

The estimated cost basis for CENTERWELL HEALTH SERVICES I (GTIV) stake is around $15.06 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$15.06
Weighted AVG sell price:
$15.06

David Abrams's historical trades in CENTERWELL HEALTH SERVICES I

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2014 Q3
0.00%
$15.06
-100% (-975,170)
2014 Q2
1.04%
$15.06
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.